Showing 1 - 7 results of 7 for search 'Tian fu Wen', query time: 0.04s Refine Results
  1. 1
    Postoperative Low Absolute Lymphocyte Counts may Predict Poor Outcomes of Hepatocellular Carcinoma After Liver Resection

    Postoperative Low Absolute Lymphocyte Counts may Predict Poor Outcomes of Hepatocellular Carcinoma After Liver Resection by Ming Wang, Chuan Li, Tian-Fu Wen, Wei Peng, Li-Ping Chen

    Published 2016-01-01
    Get full text
    Article
  2. 2
    A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma.

    A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma. by Wei Peng, Jia-Wu Li, Xiao-Yun Zhang, Chuan Li, Tian-Fu Wen, Lv-Nan Yan, Jia-Yin Yang

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation.

    Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. by Chuan Li, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Ming-Qing Xu, Wen-Tao Wang, Yong-Gang Wei

    Published 2013-01-01
    Get full text
    Article
  4. 4
    A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

    A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization by Chang Liu, Lei Li, Wu-sheng Lu, Hua Du, Lu-nan Yan, Tian-fu Wen, Wu-ran Wei, Li Jiang, Ming-qing Xu

    Published 2018-02-01
    Get full text
    Article
  5. 5
    Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

    Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. by Chuan Li, Kai Mi, Tian fu Wen, Lu nan Yan, Bo Li, Jia ying Yang, Ming qing Xu, Wen tao Wang, Yong gang Wei

    Published 2011-01-01
    Get full text
    Article
  6. 6
    Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation

    Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation by Chuan Li, M.D., Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Ming-Qing Xu, Wen-Tao Wang, Yong-Gang Wei

    Published 2012-07-01
    Get full text
    Article
  7. 7
    Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

    Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study by Guo‐Ming Shi, Xiao‐Yong Huang, Tian‐Fu Wen, Tian‐Qiang Song, Ming Kuang, Hai‐Bo Mou, Le‐Qun Bao, Hai‐Tao Zhao, Hong Zhao, Xie‐Lin Feng, Bi‐Xiang Zhang, Tao Peng, Yu‐Bao Zhang, Xiang‐Cheng Li, Hong‐Sheng Yu, Yu Cao, Lian‐Xin Liu, Ti Zhang, Wei‐Lin Wang, Jiang‐Hua Ran, Ying‐Bin Liu, Wei Gong, Ming‐Xia Chen, Lian Cao, Yang Luo, Yan Wang, Hui Zhou, Guo‐Huan Yang, Jia Fan, Jian Zhou

    Published 2023-02-01
    Get full text
    Article

Search Tools: